Delivery Order SPE2DB20D2104-SPE2DB22FS75W

Award Date 5/17/22
Potential Completion Date 5/18/22
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL to the Defense Logistics Agency (DLA). The contract, valued at $1,491.34, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 18, 2022 with a completion date of July 19, 2022. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 12, 2025, with a completion date of February 13, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL syringes to the Defense Logistics Agency (DLA). The $1,465.38 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 4, 2021 and was awarded on August 3, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL, a prescription medication, to the Defense Logistics Agency (DLA). The $4,389.87 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has an ultimate completion date of October 12, 2023 and was not set aside for any specific program. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL pharmaceutical products to the Defense Logistics Agency (DLA). The $1,187.60 fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,663.39 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of July 7, 2023 and was awarded on July 6, 2023. This award is under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds...
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml medication to the Defense Logistics Agency (DLA). The $1,706.28 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 13, 2023 and was awarded on September 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order with a firm fixed price of $1,672.16 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,187.60 and a completion date of June 8, 2023. It is a delivery order under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml to the Defense Logistics Agency (DLA). The $2,440.77 firm fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc., doing business as Amerisourcebergen Drug Corp. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FS75W
    Delivery Order

This federal contract award is for the delivery of Lantus Solostar 100 Unit/mL 3mL prescription medication to the Defense Logistics Agency (DLA). The $1,743.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 17, 2022. The award has a completion date of May 18, 2022 and is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. This IDC enables Amerisourcebergen to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, and other critical healthcare commodities, to support military treatment facilities and veterans' healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:47 AM